Found: 1
Select item for more details and to access through your institution.
ZUMA‐22: A PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL (AXI‐CEL) VS STANDARD‐OF‐CARE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 853, doi. 10.1002/hon.3166_OT31
- By:
- Publication type:
- Article